WilliamCDooleyMD

General Surgery • Oklahoma City, OK

Breast, Surgical Oncology (Other than Breast)

The G. Rainey Williams Professor and Chair Surgical Oncology

Join to view full profile

Dr. Dooley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dooley's full profile

Already have an account?

Office
825 Ne 10th St
OUPB 4G
Oklahoma City, OK 73104
Phone+1 405-271-7867

Fax+1 405-271-4443

Summary

Dr. William Dooley is a general surgeon in Oklahoma City, OK and is affiliated with multiple hospitals in the area, including OU Health and SSM Health St. Anthony Hospital - Oklahoma City. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 35 years. He also speaks multiple languages, including Spanish. He specializes in breast and surgical oncology (other than breast) and is experienced in endocrine surgery, breast surgery, surgical oncology (non-breast), pseudomyxoma peritonei, and general / gastrointestinal surgery. He has more than 80 publications and over 500 citings.

Education & Training

The Johns Hopkins Universitypost grad, Surgery/ Surgical Oncology, 1982 - 1988
Johns Hopkins University School of MedicineFellowship, Complex General Surgical Oncology, 1988
Johns Hopkins UniversityResidency, Surgery, 1987
Oxford Universitypost grad, 1986 - 1986
Johns Hopkins UniversityInternship, Surgery, 1982 - 1983
Vanderbilt University School of MedicineClass of 1982

Certifications & Licensure

MD State Medical License 1987 - 2026
OK State Medical License 2001 - 2026
AL State Medical License 1984 - 2024
American Board of Surgery Surgery

Awards, Honors, & Recognition

America's Top Doctors for 25 years Castle Connolly, 2024
Oklahoma Magazine Top Doctors for 25 years Castle Connolly, 2024
America's Top Doctors for Cancer for 25 years Castle Connolly, 2024
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women Start of enrollment: 1999 May 01
Completed
Phase 3
Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer Start of enrollment: 2001 Aug 01
Unknown status
Phase 2
Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer Start of enrollment: 2001 Aug 01
Unknown status
Phase 2
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women Start of enrollment: 2003 Jan 01
Completed
Phase 2
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer Start of enrollment: 2004 Dec 03
Completed
Phase 3
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
Active, not recruiting
Phase 3
Study of Breast Cancer Prevention by Letrozole in High Risk Women Start of enrollment: 2006 Oct 01
Completed
Phase 2
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) Start of enrollment: 2008 May 01
Unknown status
Phase 2
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3 Start of enrollment: 2008 Jul 10
Completed
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors Start of enrollment: 2010 Nov 01
Unknown status
Phase 3
Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer Start of enrollment: 2011 Jan 01
Terminated
Phase 2
NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Completed
MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I Start of enrollment: 2011 Oct 01
Completed
Phase 4
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01
Completed
Phase 2
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Completed
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® Start of enrollment: 2012 May 08
Active, not recruiting
Not Applicable
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry Start of enrollment: 2015 Nov 01
Completed
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Recruiting
Phase 3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

41 citations
Blocking the Adhesion Cascade at the Premetastatic Niche for Prevention of Breast Cancer Metastasis
Shin Ae Kang, Nafis Hasan, Aman P. Mann, Wei Zheng, Lichao Zhao
Molecular Therapy. 2015-06-01
Ductoscopy--increasing clinical utility.
William C. Dooley
The Breast Journal. 2009-07-01
12 citations
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma.
Natalie Hills, Natalie Hills, Macall Leslie, Rachel Davis, Marielle Crowell
Annals of Surgical Oncology. 2021-03-21

Press Mentions

OU Health Stephenson Cancer Center Study Emphasizes Rapid Surgical Response to Breast Cancer DiagnosisApril 20th, 2021

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Surgeons - ACS
Member

Other Languages

Spanish